Skip to main content
. 2012 Sep 12;2012(9):CD008354. doi: 10.1002/14651858.CD008354.pub2

Comparison 1. Endothelin receptor antagonist versus placebo.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 DIND 3 1976 Risk Ratio (M‐H, Fixed, 95% CI) 0.80 [0.67, 0.95]
2 Mortality 4 2010 Risk Ratio (M‐H, Fixed, 95% CI) 1.05 [0.77, 1.45]
3 Angiographic vasospasm 3 1588 Risk Ratio (M‐H, Random, 95% CI) 0.62 [0.52, 0.72]
4 Unfavorable outcome 3 1976 Risk Ratio (M‐H, Fixed, 95% CI) 0.87 [0.74, 1.02]
5 Hypotension 4 2008 Risk Ratio (M‐H, Fixed, 95% CI) 2.53 [1.77, 3.62]
6 Pneumonia 3 1976 Risk Ratio (M‐H, Fixed, 95% CI) 1.56 [1.23, 1.97]